Diales PLC Purchase of Own Shares

RNS Number : 5073D

Diales PLC

10 September 2024

 

Diales plc

("Diales" or the "Company")

Purchase of Own Shares

Further to the confirmation of its intention to implement a share buyback programme, as set out in its announcement on 12 June 2024, Diales announces that yesterday, it purchased a total of 100,000 of its ordinary shares at a price of 27.00p pence per share through Singer Capital Markets. The ordinary shares purchased will be held in treasury.

 

Aggregated information

 

Date of purchase	9 September 2024
Number of ordinary shares purchased	100,000
Highest price paid per share	27.00p
Lowest price paid per share	27.00p
Volume weighted average price paid	27.00p

 

 

Transaction details

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018), a detailed breakdown of individual trades is available below:

 

 

Number of ordinary shares purchased	Transaction price (GBP)	Time of transaction	Trading venue
100,000	27.00p	10:16:45	AIMX

 

Total voting rights

 

Following the purchase, the Company's total issued share capital consists of 53,962,868, of which 1,414,046 shares are held in treasury, therefore, the total number of Ordinary shares carrying voting rights is 52,548,822. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Diales plc	020 7377 0005
Mark Wheeler (CEO)
Charlotte Parsons (CFO)
Singer Capital Markets (Nomad & Broker)	020 7496 3000
Sandy Fraser
Jen Boorer
Acuitas Communications	020 3745 0293 / 07799 767676
Simon Nayyar	[e-mail]

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSSSEEFUELSEFU